Answers are grounded in this paper and cite their sources.
Patients with end-stage kidney disease (ESKD) will generally receive either haemodialysis (HD) or peritoneal dialysis (PD). However, this last treatment is underused, as many patients are deemed ineligible. In this article, Joanne Bargman and Hao Yan highlight the advantages of PD and explore what type of patient the treatment could benefit, as well as when PD is contraindicated
No takes yet. Share an insight, caveat, or question.
Bargman et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: